Menu
Product
TruScreen Device Overview
Clinical Performance
Development History
Markets and Distributors
Cervical Cancer
FAQ
Company
Company Information
People
FAQ
Investor Centre
NZX/ASX Announcements
Company Information
Corporate Governance
Financial Information
Shareholder Support
FAQ
Contact
NZX Interview with TruScreen CEO Martin Dillon
TruScreen, which offers the latest technology in cervical screening, listed on the NZAX on 12 November 2014. CEO Martin Dillon talks about how the listing fits into the company’s strategy and what it means to him personally.
Previous
All
Next